Mutual funds holding Onesource Specialty Pharma shares
57 mutual fund schemes held Onesource Specialty Pharma shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹2,148 cr in all. The largest holders by value are Motilal Oswal Large and Midcap Fund (3.0% of the fund), Motilal Oswal Flexi Cap Fund (2.9% of the fund), Motilal Oswal ELSS Tax Saver Fund (3.6% of the fund).
Against the month before, 2 schemes added Onesource Specialty Pharma as a new holding and 0 sold out of it completely.
New holders: TrustMF Small Cap Fund, TrustMF Multi Cap Fund
By category: Index Fund (28), Sectoral/Thematic (9), Flexi Cap (6), Small Cap (5), Large & Mid Cap (3), Value / Contra (2).
8 actively managed schemes holding it are rated A+ or A on their track record, among them Motilal Oswal Large and Midcap Fund, Motilal Oswal Flexi Cap Fund, Aditya Birla Sun Life Value Fund, 360 ONE Flexicap Fund, Bajaj Finserv Flexi Cap Fund.
Every scheme holding Onesource Specialty Pharma, by value
And 17 more schemes with smaller holdings.
Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.
Common questions
How many mutual funds hold Onesource Specialty Pharma shares?
57 schemes held Onesource Specialty Pharma in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹2,148 cr in all.
Which mutual fund holds the most Onesource Specialty Pharma shares?
By value, Motilal Oswal Large and Midcap Fund: about ₹599 cr, 3.04% of the fund.
Where does this data come from?
From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.
This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.
Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.